Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin
India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Govt
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap
Germany to recognize Covaxin for travel from June 1
Govt may not allow mixing of Covid vaccines for booster shots
Vaccine fatigue? Complacency confusion fear behind reluctance to take Covid booster says experts
In first quantitative sero-survey in Mumbai, 99.93 pc participants found with COVID-19 antibodies
No impact of WHO action on Covaxin, have not supplied to any UN agency: Bharat Biotech
Guidelines on Covaxin for under 18 don’t mention EUL by WHO: Health Ministry
Mix & Match of Covaxin, Covishield elicits 4 times antibody response, says study
For now, Covaxin likely to be only Covid vaccine available for children of 15-18 yrs